Videos

Forward Thinking to Improve SUDEP Prevention, Awareness: Orrin Devinsky, MD

November 25, 2021

The director of the Comprehensive Epilepsy Center at NYU Langone provided closing thoughts on how clinicians can begin to shift gears from research to prevention of SUDEP. [WATCH TIME: 2 minutes]

Choosing Treatments for Patients With Multiple Sclerosis: Devon Conway, MD

November 24, 2021

Discussing newer treatment options in the MS field, the staff neurologist in the Neurological Institute’s Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic noted that patient preference can play a part in the decision-making process. [WATCH TIME: 3 minutes]

Treating Insomnia With Related Comorbid Conditions: Michael Thorpy, MD

November 24, 2021

The director of the Sleep-Wake Disorders Center at Montefiore Medical Center provided knowledge on how the presence of other comorbid sleep disorders affects patients with insomnia. [WATCH TIME: 2 minutes]

New Medications for Multiple Sclerosis Treatment: Devon Conway, MD

November 23, 2021

The staff neurologist in the Neurological Institute’s Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic discussed emerging treatments in the MS field. [WATCH TIME: 2 minutes]

Ubrogepant for Acute Migraine Treatment

November 23, 2021

A migraine specialist examines the efficacy and safety of oral CGRP antagonist ubrogepant for the acute treatment of migraine.

The Impact of CGRP Antagonists on Chronic Migraine

November 23, 2021

Dr David Kudrow discusses how CGRP antagonist treatments have affected chronic migraine, including the effect on quality of life.